​

GeneDx (WGS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

GeneDx Revenue Highlights

Latest Revenue (Y)

$305.45M

Latest Revenue (Q)

$102.69M

Main Segment (Y)

Diagnostic Test

Main Geography (Y)

Other

GeneDx Revenue by Period

GeneDx Revenue by Year

DateRevenueChange
2024-12-31$305.45M50.79%
2023-12-31$202.57M-13.69%
2022-12-31$234.69M10.60%
2021-12-31$212.19M18.33%
2020-12-31$179.32M-8.59%
2019-12-31$196.17M-

GeneDx generated $305.45M in revenue during NA 2024, up 50.79% compared to the previous quarter, and up 155.70% compared to the same period a year ago.

GeneDx Revenue by Quarter

DateRevenueChange
2025-06-30$102.69M17.88%
2025-03-31$87.11M-8.91%
2024-12-31$95.64M24.41%
2024-09-30$76.87M9.02%
2024-06-30$70.51M12.96%
2024-03-31$62.42M8.72%
2023-12-31$57.42M7.72%
2023-09-30$53.30M9.44%
2023-06-30$48.71M12.90%
2023-03-31$43.14M-29.68%
2022-12-31$61.35M-26.29%
2022-09-30$83.23M130.13%
2022-06-30$36.17M-32.95%
2022-03-31$53.94M-6.68%
2021-12-31$57.80M33.87%
2021-09-30$43.18M-7.87%
2021-06-30$46.87M-27.00%
2021-03-31$64.20M0.38%
2020-12-31$63.96M65.66%
2020-09-30$38.61M-

GeneDx generated $102.69M in revenue during Q2 2025, up 17.88% compared to the previous quarter, and up 164.51% compared to the same period a year ago.

GeneDx Revenue Breakdown

GeneDx Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 22
Diagnostic Test$302.16M$227.33M
Diagnostic Test, Institutional Customers$65.11M-
Diagnostic Test, Self Pay$2.34M-
Diagnostic Test, Third Party Insurance$234.70M-
Product and Service, Other$3.29M$7.36M

GeneDx's latest annual revenue breakdown by segment (product or service), as of Dec 24: Diagnostic Test (49.73%), Diagnostic Test, Third Party Insurance (38.63%), Diagnostic Test, Institutional Customers (10.72%), Product and Service, Other (0.54%), and Diagnostic Test, Self Pay (0.39%).

Quarterly Revenue by Product

Product/ServiceJun 25Mar 25Dec 24Sep 24Jun 24
Diagnostic Test, Self Pay$339.00K$96.00K$1.19M$460.00K$692.00K
Diagnostic Test, Institutional Customers$18.38M$17.60M$31.00M$17.41M$16.70M
Diagnostic Test$99.82M$85.76M$155.30M$77.42M$69.44M
Diagnostic Test, Third Party Insurance$81.10M$68.06M$123.10M$59.54M$52.05M
Product and Service, Other$2.87M$1.36M$2.76M$-544.00K$1.07M

GeneDx's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Diagnostic Test (49.29%), Diagnostic Test, Third Party Insurance (40.05%), Diagnostic Test, Institutional Customers (9.08%), Product and Service, Other (1.42%), and Diagnostic Test, Self Pay (0.17%).

GeneDx Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24
Other$3.16M

GeneDx's latest annual revenue breakdown by geography, as of Dec 24: Other (100.00%).

GeneDx Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
WGSGeneDx$305.45M$102.69M
TALKTalkspace$187.59M$48.72M

WGS Revenue FAQ

What is GeneDx’s yearly revenue?

GeneDx's yearly revenue for 2024 was $305.45M, representing an increase of 50.79% compared to 2023. The company's yearly revenue for 2023 was $202.57M, representing a decrease of -13.69% compared to 2022. WGS's yearly revenue for 2022 was $234.69M, representing an increase of 10.60% compared to 2021.

What is GeneDx’s quarterly revenue?

GeneDx's quarterly revenue for Q2 2025 was $102.69M, a 17.88% increase from the previous quarter (Q1 2025), and a 45.63% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $87.12M, a -8.91% decrease from the previous quarter (Q4 2024), and a 39.56% increase year-over-year (Q1 2024). WGS's quarterly revenue for Q4 2024 was $95.64M, a 24.41% increase from the previous quarter (Q3 2024), and a 66.57% increase year-over-year (Q4 2023).

What is GeneDx’s revenue growth rate?

GeneDx's revenue growth rate for the last 3 years (2022-2024) was 30.15%, and for the last 5 years (2020-2024) was 70.34%.

What are GeneDx’s revenue streams?

GeneDx's revenue streams in c 24 are Diagnostic Test, Diagnostic Test, Institutional Customers, Diagnostic Test, Self Pay, Diagnostic Test, Third Party Insurance, and Product and Service, Other. Diagnostic Test generated $302.16M in revenue, accounting 49.73% of the company's total revenue, up 32.91% year-over-year. Diagnostic Test, Institutional Customers generated $65.12M in revenue, accounting 10.72% of the company's total revenue Diagnostic Test, Self Pay generated $2.34M in revenue, accounting 0.39% of the company's total revenue Diagnostic Test, Third Party Insurance generated $234.7M in revenue, accounting 38.63% of the company's total revenue Product and Service, Other generated $3.29M in revenue, accounting 0.54% of the company's total revenue, down -55.26% year-over-year.

What is GeneDx’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of GeneDx was Diagnostic Test. This segment made a revenue of $302.16M, representing 49.73% of the company's total revenue.